Johnson Matthey (LON:JMAT – Free Report) had its target price increased by Berenberg Bank from GBX 2,300 to GBX 2,550 in a research note published on Wednesday,Digital Look reports. The firm currently has a buy rating on the stock.
A number of other equities research analysts also recently weighed in on the company. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 2,330 price target on shares of Johnson Matthey in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 price objective on shares of Johnson Matthey in a research note on Monday, July 6th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Johnson Matthey currently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,370.
View Our Latest Stock Report on JMAT
Johnson Matthey Trading Down 1.8%
LON:JMAT opened at GBX 2,394 on Wednesday. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The business’s 50 day moving average is GBX 2,358.85 and its two-hundred day moving average is GBX 2,152.72. Johnson Matthey has a 52 week low of GBX 2,192 and a 52 week high of GBX 3,245.33. The company has a market cap of £3.01 billion, a PE ratio of -31.39, a P/E/G ratio of 49,242.50 and a beta of 0.88.
Insider Buying and Selling
In related news, insider Alastair Judge bought 12 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was bought at an average cost of GBX 2,193 per share, for a total transaction of £263.16. Also, insider Liam Condon bought 10,951 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was bought at an average price of GBX 2,306 per share, with a total value of £252,530.06. Insiders have acquired a total of 28,608 shares of company stock worth $64,947,512 over the last quarter. 0.77% of the stock is owned by company insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
